105 related articles for article (PubMed ID: 11372904)
1. Onset of illegal use of mind-altering or potentially addictive prescription drugs among pharmacists.
Dabney DA
J Am Pharm Assoc (Wash); 2001; 41(3):392-400. PubMed ID: 11372904
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing pharmacists' preference for the legal classification of Rx-to-OTC switched drug products.
Madhaven S
J Clin Pharm Ther; 1993 Aug; 18(4):281-90. PubMed ID: 8227236
[TBL] [Abstract][Full Text] [Related]
3. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
Shepherd MD
J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
[TBL] [Abstract][Full Text] [Related]
4. The role of perceived impact on relationship quality in pharmacists' willingness to influence indication-based off-label prescribing decisions.
Basak R; Bentley JP; McCaffrey DJ; Bouldin AS; Banahan BF
Soc Sci Med; 2015 May; 132():181-9. PubMed ID: 25818379
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing community pharmacists' likelihood to ask medication monitoring questions: A factorial survey.
Witry MJ; Doucette WR
Res Social Adm Pharm; 2015; 11(5):639-50. PubMed ID: 25573019
[TBL] [Abstract][Full Text] [Related]
6. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
7. Results from a mailed promotion of medication reviews among Department of Defense beneficiaries receiving 10 or more chronic medications.
Linton A; Bacon TA; Trice S; Devine J; Cottrell L; McGinnis TJ; McAllister EB
J Manag Care Pharm; 2010 Oct; 16(8):578-92. PubMed ID: 20866163
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
[TBL] [Abstract][Full Text] [Related]
9. Pharmacists' attitudes regarding quality of worklife.
McHugh PP
J Am Pharm Assoc (Wash); 1999; 39(5):667-76. PubMed ID: 10533348
[TBL] [Abstract][Full Text] [Related]
10. Pharmacists and patients feedback on empirically designed prescription warning labels: a qualitative study.
Shiyanbola OO; Smith PD; Huang YM; Mansukhani SG
Int J Clin Pharm; 2017 Feb; 39(1):187-195. PubMed ID: 28070688
[TBL] [Abstract][Full Text] [Related]
11. British community pharmacists' views of physician-assisted suicide (PAS).
Hanlon TR; Weiss MC; Rees J
J Med Ethics; 2000 Oct; 26(5):363-9. PubMed ID: 11055040
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of substance use by pharmacists and other health professionals.
Kenna GA; Wood MD
J Am Pharm Assoc (2003); 2004; 44(6):684-93. PubMed ID: 15637851
[TBL] [Abstract][Full Text] [Related]
14. Do pharmacists' opinions affect their decision to dispense or recommend a visit to a doctor?
Caamaño-Isorna F; Montes A; Takkouche B; Gestal-Otero JJ
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):659-64. PubMed ID: 15830396
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist prescribing: a cross-sectional survey of the views of pharmacists in Nigeria.
Auta A; Strickland-Hodge B; Maz J; David S
Int J Pharm Pract; 2018 Apr; 26(2):111-119. PubMed ID: 28497878
[TBL] [Abstract][Full Text] [Related]
16. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
[TBL] [Abstract][Full Text] [Related]
17. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.
Norwood CW; Wright ER
Res Social Adm Pharm; 2016; 12(2):257-66. PubMed ID: 26143489
[TBL] [Abstract][Full Text] [Related]
18. Prescription drug diversion among substance-impaired pharmacists.
Merlo LJ; Cummings SM; Cottler LB
Am J Addict; 2014; 23(2):123-8. PubMed ID: 25187048
[TBL] [Abstract][Full Text] [Related]
19. [Information transmission to the community pharmacist after a patient's discharge from the hospital: setting up of a written medication discharge form, prospective evaluation of its impact, and survey of the information needs of the pharmacists].
Claeys C; Dufrasne M; De Vriese C; Nève J; Tulkens PM; Spinewine A
J Pharm Belg; 2015 Mar; (1):42-54. PubMed ID: 26571796
[TBL] [Abstract][Full Text] [Related]
20. Children/young people taking long-term medication: a survey of community pharmacists' experiences in England.
Aston J; Wilson KA; Terry DRP
Int J Pharm Pract; 2018 Apr; 26(2):104-110. PubMed ID: 28370586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
